Trimi GLP-1 Reviews: Is Trimi Health Legit?

Affiliate disclosure: The RX Index may earn a commission from links on this page marked "Sponsored." Links marked "Provider site" go directly to the provider. It does not change our verdict, our sources, or the parts of this page where we tell you not to use Trimi.

These Trimi GLP-1 reviews lead to one clear verdict: Trimi is a real, operating telehealth program with real prices — but we would not start on the annual plan. Trustpilot has taken Trimi's rating down for breaking its rules and says it removed fake reviews from the page. Reviews.io shows 4.6 out of 5. The two sites show very different pictures. Start month-to-month, and check which pharmacy would fill your order before a clinician writes your prescription, because one of Trimi's two named pharmacies was ordered in May 2026 to stop shipping compounded prescriptions into California.

That's the short answer. Here's the part almost nobody tells you: the reason those two ratings look nothing alike has a simple explanation, and once you understand it, you'll be able to read the reviews for any GLP-1 company in about sixty seconds. We'll show you how below.

We pulled two Texas inspection files for the license number Trimi publishes, and we pulled California's enforcement order for its other named pharmacy. What we found in those documents is the most useful thing on this page — part of it is genuinely good news for Trimi, and part of it you need to read before you spend a dollar.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Our verdict at a glance

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose. → Find My GLP-1 Path

What we actually verified

We want you to know exactly how much weight to put on this page.

What we checked, on August 28, 2026:

• Trimi's current pricing, refund, terms, provider, state and pharmacy pages
• Trimi's Trustpilot profile, captured the same day
• Trimi's Reviews.io profile, captured the same day
• The Texas State Board of Pharmacy inspection files for pharmacy license #35264, dated February 5, 2025 and March 18, 2026
• The California State Board of Pharmacy enforcement record for Greenwich Rx
• The FDA's warning-letter database
• The FDA's current guidance on compounded GLP-1 medications
• Ro's current pricing and free insurance-coverage checker

Provider-stated versus independently verified

What we did not do:

• We were not Trimi patients. We did not buy a plan or receive medication.
• We did not lab-test a vial. We found no public independent finished-vial lab report tied to a Trimi shipment, so we cannot verify the contents or potency of any Trimi vial from public evidence.
• We did not check every clinician's license in every state.
• We did not time their support responses ourselves.

Everything below is either a document you can open yourself or a clearly labeled judgment call. Where a company says something we couldn't confirm, we say "Trimi states" instead of stating it as fact.

Is Trimi Health legit?

Trimi Health is a real telehealth business operating at trytrimi.com. Its site says "Established 2024." It publishes its prices, its refund policy, the name of its public-facing clinical group, and the names of its pharmacies. That clears the "is this an anonymous scam storefront" bar. It does not settle whether the company is the right choice for you.

Here's how the pieces fit together, because a lot of people misunderstand this part.

Trimi is the platform. It doesn't write your prescription and it doesn't make your medication. Three separate businesses are involved:

• Trimi Health — the website, the app, the billing, the customer support.
• Arora Health — the clinical group. Trimi states its clinicians are licensed across all 50 states, led by medical director Dr. Sean Arora, MD. A clinician here reviews your intake and decides whether to prescribe.
• The pharmacy — a state-licensed compounding pharmacy actually mixes and ships your vial. Trimi names two: VialsRx and Greenwich Rx.

Naming the pharmacy matters. A named pharmacy gives you something concrete to check. Trimi gives you names and even publishes a Texas license number. Credit where it's due — that's real transparency, and we used it.

We just didn't like everything we found when we used it. More on that shortly.

There is also one legal-page mismatch you should know. Trimi's current public care pages name Arora Health, VialsRx and Greenwich Rx, while its current Terms of Service still name Beluga Health, P.A. and the Bask Pharmacy Network. That does not prove the live service uses the older names. It does mean the legal pages do not cleanly match the sales pages. Ask Trimi to confirm in writing which clinical group and pharmacy will handle your order.

One number worth sitting with: Trimi's homepage says "50,233+ patients." Between both public review sites, there are 139 reviews total — 62 on Trustpilot and 77 on Reviews.io. That gap isn't proof of anything by itself. Most happy customers never write reviews. But it does mean the public record on this company is thin, and thin records are easy to move in either direction.

Sources: Trimi homepage, Trimi providers, Trimi Terms of Service, Trustpilot, Reviews.io.

Why do Trimi's reviews look so different depending on where you look?

Trimi's ratings disagree because the two platforms collect reviews in different ways. Reviews.io shows 4.6 out of 5 from 77 reviews, with 87% recommending Trimi. Trustpilot lets anyone post, and its 62 reviews run 53% one-star — except Trustpilot has now removed Trimi's score entirely, stating the company breached its guidelines and that fake reviews were removed from the profile.

This is the single most important section on this page, so we're going to slow down.

Every Trimi rating, side by side

The plain-English translation

Invitation-based reviews and open reviews do not sample the same people. Reviews.io says its business clients request reviews after real transactions, and that genuine verified reviews stay visible even when they are negative. Trustpilot lets people seek out the profile and post on their own. Neither score is a census of every Trimi customer.

So a 4.6 from mostly invited, verified buyers and a wall of one-stars from people who chose an open platform can both be honest pictures of the same company. They're pictures of two different groups.

What is not normal is the rating being taken down. Trustpilot removing a score and saying it removed fake reviews is a different kind of signal than a low score. A low score means customers were unhappy. A removed score means the platform found reviews it judged weren't from real experiences. Trustpilot doesn't say who submitted them, and neither will we.

How to check any GLP-1 company's reviews in 60 seconds

Keep this. It works on every provider, including the ones we recommend.

1. Can anyone post, or are most reviews invited? An invitation system can verify a purchase, but it still measures the people reached through that system.
2. What labels do the platforms use? "Verified Buyer" and "Unprompted review" tell you how the review arrived. They do not tell you whether every claim inside it is true.
3. Did a batch land on one day? That can show a review-request campaign, not a sudden change in care.
4. Does the number on the company's site match the platform? Trimi's site says 4.57 and 4.9 in different places. The platforms say 4.6 and "unavailable."
5. Is there a BBB file? No file means there is no BBB complaint history for you to inspect — good or bad.

What people actually say

Two real, dated reviews from Reviews.io, both from verified buyers, that show the split:

"Very happy with their customer support as well as their products." — Melissa May, verified buyer, August 2026

"It took over 2 weeks for me to get a response." — Anonymous verified buyer, August 2026

And one from Trustpilot that captures a repeated complaint we saw:

"I have requested the COA and followed up… three weeks later still no COA." — Ashley, Trustpilot; experience dated July 25, posted August 15, 2026

These are individual experiences. They don't prove what typical service looks like, and a customer's weight change can't prove what a vial contains. We're showing them because they're real, they're attributable, and they're the honest range.

Why we are not publishing a Trimi score

The RX Index scores providers on five pillars — clinical legitimacy, care quality, transparency, access, and cost. We are not publishing a number for Trimi yet. Two of those pillars don't have enough clean evidence to score honestly, and a score you can't defend is worse than no score at all. Averaging a removed Trustpilot rating with an invited Reviews.io rating would be making up precision that doesn't exist.

Sources: Trustpilot's Trimi profile, Reviews.io's Trimi profile, Reviews.io consumer FAQ, Trimi homepage, Trimi tirzepatide page.

How much does Trimi actually cost?

Trimi's advertised $99 semaglutide and $125 tirzepatide prices are the effective monthly rate on a full year paid up front — $1,188 and $1,500 in a single charge. The flexible month-to-month prices are $175 for compounded semaglutide and $235 for compounded tirzepatide. The advertised price does not increase as your dose increases on any plan.

The "$99 a month" headline leaves out the first charge. Here is what each plan actually charges you.

Compounded semaglutide — every plan

Compounded tirzepatide — every plan

Trimi also advertises $50 off your first month with code 50OFF, and a $50 credit for referring a friend. Confirm both at checkout before you assume they applied.

The number that should drive your decision

Look at month one, not month twelve.

• Semaglutide: starting monthly costs you $175. Starting annual costs you $1,188. That's $1,013 you haven't put at risk while you find out whether this company actually works for you.
• Tirzepatide: $235 versus $1,500. That's $1,265 still in your pocket during the only month where you learn anything.

Is the annual plan cheaper over a year? Yes — $912 cheaper on semaglutide, $1,320 on tirzepatide. That's real money and we're not going to pretend otherwise. The question is whether you want to hand over a year of payments to a company before you've seen a single shipment arrive, gotten one support reply, or found out which pharmacy fills your order.

We don't think you do. Not for a first order.

Choose your plan by what you know today

Our one honest knock on Trimi

Trimi does not promise a clean way out once your prescription is written. Its current policy says an ordinary order is final at that point, even if nothing has shipped. It does not promise pro-rated refunds. The same policy also has a six-month money-back promise and says discounted multi-month early exits are reviewed case by case. That is not the same as a guaranteed exit.

But here's the trade Trimi is offering, and it's a real one: strict ordinary refund terms paired with a price that stays flat at every listed dose.

That last part matters more than most people realize. On a dose-based pricing plan, your bill climbs each time your dose goes up — so your cost rises at exactly the moment you're trying to stay consistent. Trimi's advertised price doesn't move.

A verified Reviews.io buyer said she had been able to change doses with no price change. That is one customer's experience, but it matches Trimi's published pricing structure.

Flat dose pricing is Trimi's single best feature. It's the reason to consider them at all. And you get that flat price on the month-to-month plan too — you just pay more per month for the freedom to leave.

If that trade sounds right to you, start on the flexible plan.

→ See Trimi's current plans and check eligibility (Provider site) The lowest rates require a full year up front. We'd start month-to-month.

Source: Trimi's current pricing and promotion page, verified August 28, 2026.

Can you cancel Trimi or get a refund?

Trimi's published policy gives you a full refund if you cancel before a clinician issues your prescription, and a full automatic refund if a clinician decides you aren't a good candidate. After the prescription is issued, an ordinary order is final. Trimi says it does not pro-rate. Discounted multi-month early exits are reviewed case by case, and a separate six-month money-back promise has its own conditions.

This cutoff appears in current negative Trimi reviews. Not because the company hides the rule on its refund page, but because the cutoff arrives much earlier than people expect.

The Trimi refund clock

Most people assume their refund window closes when the medicine ships. It doesn't.

1. You pay and fill out your health intake. ← You can still cancel for a full refund
2. A clinician reviews your file. ← You can still cancel for a full refund
3. ⚠️ A clinician signs your prescription. ← This is where the ordinary cancellation door closes
4. The pharmacy compounds your medication
5. Your package ships

Trimi says this cutoff exists because the prescription and compounded medication become patient-specific. The practical point is simpler: the refund door can close before the vial is made or shipped.

If you prepay and want out later, the current policy does not promise a partial refund. It says multi-month plans bought at a discount are reviewed case by case for early exits. Get any exception in writing before you count on it.

What is and isn't refundable

Straight from Trimi's published refund policy, last updated June 17, 2026:

That bolded tension is the one to read twice. The policy says dissatisfaction with how the medication "feels" is not refundable under its ordinary rules. A separate section says people who stay on the plan, follow their provider's guidance and remain dissatisfied through the first six months may qualify for the money-back promise. Those two sections do not fit together cleanly. Ask Trimi to confirm in writing which rule would apply to your situation.

The 6-month money-back promise — and the condition everyone misses

Trimi's current policy describes two possible paths:

1. Not satisfied: tell the care team during your first six months. Trimi says it will work to fix the problem and refund plan fees if it cannot.
2. No weight loss after six months: complete a full continuous six months, follow the plan, and meet every tracking rule below.

For the no-weight-loss path, the current conditions are:

1. An active, paid plan for the whole six months.
2. Medication taken on schedule and dose kept as directed.
3. Provider check-ins completed.
4. A starting weight logged in your patient portal. ← this is the one people miss
5. An updated weight logged at your six-month mark.
6. The claim filed within 30 days of that six-month mark. One claim per patient.

"Didn't lose weight" means no net loss between those two logged weigh-ins. Without both weights, Trimi says the claim can't be verified, so it can't be approved.

Trimi also describes this as a commercial satisfaction promise, not a medical guarantee. That's the right way to describe it, and we'd say the same.

So here is the single most valuable instruction on this page: if you start with Trimi, log your starting weight in the portal on day one, before your first injection, and take a screenshot. It takes 30 seconds and it may be the difference between having a documented refund path and not having one.

One more thing in the fine print

Trimi's current Terms of Service say most disputes must be resolved through binding individual arbitration in New York under American Arbitration Association rules, with limited court exceptions. We did not find the draft's claimed 30-day arbitration opt-out. The arbitration section does not use the words “class action,” but “binding individual arbitration” still limits how a dispute can be brought. The terms also name Beluga Health and Bask Pharmacy Network in places where Trimi's public care pages name Arora Health, VialsRx and Greenwich Rx.

That is the kind of legal-page mismatch worth knowing before you send someone $1,500.

Before you pay: the 60-second checklist

Screenshot or save all of this before you enter a card:

• The exact plan you selected and the total first charge
• Today's version of the refund policy
• A written answer to: when is my prescription considered issued?
• A written answer to: is the full bundle charged immediately?
• A written answer to: what happens to unused prepaid months if I leave early?
• The exact clinical group and pharmacy that would handle your order
• Today's version of the arbitration section in the Terms of Service

This is the free Before-You-Pay Checklist. Save this section or print the page. It works with any GLP-1 provider, not just this one.

Sources: Trimi Refund & Cancellation Policy, Trimi Terms of Service. Both checked August 28, 2026.

What pharmacy does Trimi use?

Trimi names two 503A compounding pharmacies — VialsRx, tied to Texas pharmacy license #35264, and Greenwich Rx. We checked both against state records. Texas inspection files recorded zero deficiencies on the warning notice for license #35264 in February 2025 and again in a newer March 18, 2026 change-of-location inspection. Greenwich Rx was ordered by the California State Board of Pharmacy in May 2026 to stop shipping compounded prescriptions into California.

First, a definition, because this term is everywhere and rarely explained: a 503A pharmacy compounds medication for an individual patient based on that patient's prescription. It is licensed mainly through state pharmacy boards, while FDA still has federal authority over compounding law. A 503B "outsourcing facility" is a different category that registers with FDA and can compound under a different set of rules.

There is no such thing as an "FDA-approved pharmacy" or an "FDA-licensed compounding facility." If you ever see that phrase on a GLP-1 website, it's wrong.

What we found in the Texas files — the good news first

We pulled the Texas State Board of Pharmacy's inspection reports for license #35264. Here is the document trail.

The February 2025 report is the longer inspection. It recorded satisfactory findings across cleanroom controls, environmental sampling, garbing and hand hygiene, compounding records, staff training and labeling, with zero deficiencies on the warning notice.

The March 2026 report is newer. Its warning notice again recorded zero deficiencies, and the report documents the move from the Houston address to Tomball along with the new name Believe Rx.

Those are real trust signals. They are the strongest verified facts in Trimi's favor on this page.

They are not a lab test of your vial. An inspection with zero listed deficiencies tells you what state inspectors found at the facility on those dates. It does not prove the potency, sterility or shipping condition of every later prescription.

The name question is now clearer — but still worth confirming

The state documents explain why more than one name appears around license #35264:

• The February 2025 report used Vital Drip Infusion Pharmacy.
• The March 2026 report used VialsRx.
• The March 2026 report itself says the new name is Believe Rx and gives the new Tomball address.

That is much stronger than guessing that the names belong together. The Texas Board documented the change on the same license.

But if your whole question is "who is actually making my medicine," you still want the exact legal name on your prescription, label and shipping record. Ask Trimi which name will appear before a clinician issues the prescription.

Look it up yourself: use the Texas State Board of Pharmacy's license verification and search 35264. Check the name, address, status and expiration date on the day you're reading this.

The California order on Greenwich Rx

This one is not ambiguous, and California readers need to see it.

We read the California State Board of Pharmacy's own enforcement record. Effective May 18, 2026, the Board described Greenwich Rx of Tomball, Texas as an unlicensed nonresident pharmacy and unlicensed nonresident sterile compounding pharmacy in California. Under Business and Professions Code section 4316(a), the order directs Greenwich Rx to cease and desist shipping, mailing or delivering dangerous drugs, dangerous devices and prescription compounded preparations into California.

Two things must be said clearly:

1. This order names Greenwich Rx, not Trimi. California did not accuse Trimi of anything. Trimi lists Greenwich Rx as one of its pharmacy partners; that's the connection, and that's all it is.
2. We don't know which pharmacy would fill your specific order. Trimi names two. Only Greenwich Rx is named in this California order.

That's precisely why the next section exists.

Ask this before your prescription is written

Copy this and send it through Trimi's portal or contact page. You can ask before paying, or immediately after paying while the published full-refund window is still open and before a clinician issues the prescription.

Before I authorize treatment, please confirm in writing: 1. The exact legal name and address of the pharmacy that would fill my prescription. 2. Its license number and current authority to ship to my state. 3. The full formulation, including every added ingredient. 4. Whether the document you call a COA covers the finished compounded batch or only the ingredient/API lot. 5. How I can get the finished-batch potency, sterility and endotoxin test records tied to the lot on my vial. 6. Whether I can cancel for a full refund if I do not receive these answers before my prescription is issued.

A clear provider should answer those questions in writing before the prescription is issued. A provider that dodges them has told you what you needed to know.

This is the pharmacy verification message. Copy it from this page. It works with any compounded GLP-1 provider.

Sources: Texas inspection report for license #35264, March 18, 2026, Texas inspection report for license #35264, February 5, 2025, California Board of Pharmacy order listing, FDA telehealth compounding-marketing guidance.

Is Trimi available in every state?

Trimi advertises service in all 50 states and Washington, D.C. We did not independently verify prescriber licensing and pharmacy authority in every state, and the California order against Greenwich Rx means we won't repeat a blanket nationwide claim as verified. Confirm your own state in writing before a clinician issues your prescription.

We're not saying Trimi can't serve your state. We're saying we didn't verify it, so we won't tell you we did.

Trimi's current state page says Arora Health has a 50-state clinician network and that both VialsRx and Greenwich Rx ship to all 50 states. The California order shows why a general website statement is not enough for a real purchase.

If you're in California: don't rely on a general availability claim. Ask Trimi to name the exact pharmacy that would fill your order and confirm its current California authority, in writing, before the prescription is issued. If you don't get a clear answer, that's your answer.

A state you can't get confirmed is not a state you're cleared for. Unknown isn't the same as approved.

If your state is the sticking point, don't assume your only choices are Trimi or no treatment.

→ Find a GLP-1 treatment path available in your state — takes about 60 seconds, matches you on state, budget, and whether you want an FDA-approved or compounded medication.

Source: Trimi's state-availability page, checked against the California Board of Pharmacy order listing.

"It feels like nothing is happening." What to do if your Trimi medication doesn't seem to work

A repeated complaint in Trimi's current public reviews is that some customers felt no appetite change and saw no weight loss, including people who say they had responded to a GLP-1 before. Several Trustpilot reviewers also say they asked for a certificate of analysis and had trouble getting one. These are customer reports, not lab findings. We found no public independent finished-vial test tied to a Trimi shipment, so we cannot tell you what was in any reviewer's vial.

If that's you, read this part carefully. We're not selling you anything in this section.

What reviewers are reporting

Grouped by theme, from dated public reviews. These are customer accounts, not findings:

• No appetite change and no weight change over months, including reports from people who used another GLP-1 before
• Difficulty getting a certificate of analysis after repeated requests
• One reviewer stating that the document received did not match the dose and additive shown on the vial
• Slow or circular support — being passed between the support team and the clinician
• A titration schedule some reviewers described as starting lower and moving slower than programs they'd used before

On that last point, we want to be fair. A slower dose increase can be a legitimate clinical choice. Going up slowly may reduce nausea and other side effects. Dose decisions belong to a licensed clinician who knows your history — not to a review page. The point isn't that slow is wrong. The point is that you should know what schedule you were prescribed and be able to ask why.

What a certificate of analysis is — and what it may not prove

A certificate of analysis, usually shortened to COA, is a document that lists tests and results for a named batch or lot. But the words "certificate of analysis" do not always mean the same thing.

A COA may cover:

• the semaglutide or tirzepatide ingredient/API lot bought by the pharmacy, or
• the finished compounded preparation batch made by the pharmacy.

Those are not the same document. FDA's own GLP-1 import-alert materials use COAs for API lots. A finished sterile preparation may have separate potency, sterility and endotoxin records. Not every COA includes all three.

A COA also does not, by itself, prove what was in your exact vial. The pharmacy name, formulation, lot number and test date must match your label and shipment.

Trimi's website states that a certificate of analysis is available on request. Multiple dated public reviews say people asked and had trouble getting one. We could not test the process ourselves, so we're publishing both facts and letting you weigh them.

Ask for these five things by name

1. The lot or batch number printed on your vial and box
2. Whether the document covers the finished preparation or only the API lot
3. The identity and potency results, with the test date and acceptance range
4. The finished-batch sterility result, if it is not on the COA
5. The finished-batch bacterial endotoxin result, if it is not on the COA

Ask for them in writing, and make sure every lot number matches.

Copy this message:

Please send the quality records tied to the lot number on my vial. Please confirm whether the COA covers the finished compounded preparation or only the semaglutide/tirzepatide API lot. I also need the identity and potency result, test date, acceptance range, and the finished-batch sterility and bacterial endotoxin results if they are on separate reports.

This is the COA Request Kit. Copy it, add the lot number from your vial, and save every reply.

If you don't get an answer

Work down this list in order:

1. Write through the patient portal so there is a dated record.
2. Ask the dispensing pharmacy directly using the legal name and phone number on your vial label.
3. For a true billing error, duplicate charge or product that was never delivered, contact your card issuer right away. CFPB says written notice may be needed within 60 days after the charge first appeared on your statement to protect federal billing-error rights. A medication not working as hoped is not automatically a billing error.
4. File a complaint with the state pharmacy board where the dispensing pharmacy is licensed.
5. Report a suspected quality problem or adverse event to FDA MedWatch.

If you're switching, do it in this order

This is the part people get wrong and it can cost them weeks of progress:

1. Tell your current clinician what is happening. Do not change the dose on your own.
2. Request your medical records from Trimi, including the prescribed dose, dates and pharmacy information.
3. Have the new clinician review the records before you overlap, skip or restart medication.
4. Confirm the handoff and future billing, then cancel the old auto-renewal.

A long gap may cause a new clinician to lower or restart your dose. That is a clinical decision, not a rule a review page can make for you.

→ Find your next GLP-1 treatment path — if you're leaving because you weren't sure what you were injecting, the next choice matters more than the last one. We match you on state, budget, and whether you want FDA-approved or compounded.

Sources: Trustpilot's Trimi profile, Reviews.io's Trimi profile, Trimi homepage, FDA API certificate-of-analysis guidance, FDA GLP-1 Import Alert 66-80, CFPB billing-error guidance, FDA MedWatch.

Are Trimi's medications FDA-approved?

No. Trimi sells compounded semaglutide and compounded tirzepatide. Compounded medications are prepared for individual prescriptions, and the FDA has not reviewed Trimi's compounded products for safety, effectiveness or quality before sale. This is true of every compounded GLP-1 product, not just Trimi's.

This isn't a knock on Trimi specifically. It's the trade you make for the price, and you should make it with your eyes open.

The post-shortage rule matters in 2026

The semaglutide and tirzepatide shortage periods that made wider shortage-based compounding possible have ended. FDA reminded compounders on April 1, 2026 that a 503A pharmacy may not regularly compound a drug that is "essentially a copy" of a commercially available drug unless a prescriber determines and documents a change that creates a significant difference for an identified patient.

That does not mean every compounded semaglutide or tirzepatide prescription is illegal. It means the patient-specific reason matters now. A provider's website saying compounded GLP-1 is available does not prove that your own prescription meets the federal rule.

Ask your clinician one plain question:

What patient-specific medical need or documented significant difference supports a compounded product for me instead of an FDA-approved option?

You deserve an answer that is about you, not a copy-and-paste sales line.

About those weight-loss numbers you keep seeing

You'll see "14.9%" and "20.9%" on GLP-1 websites, Trimi's included. Those numbers come from published trials — STEP 1 for semaglutide and SURMOUNT-1 for tirzepatide, both in the New England Journal of Medicine.

Those trials studied the FDA-approved branded formulations used in the trials, not a Trimi-dispensed compounded vial. Trimi has not published a clinical trial of the specific compounded products it sells. It would be wrong to use the brand trial numbers as proof that a Trimi vial will produce the same result.

What FDA is seeing with compounded GLP-1 products

FDA's current consumer page says compounded GLP-1 products are not reviewed before marketing and should be used only when a patient's medical need cannot be met by an FDA-approved drug. It also warns about warm shipments, dosing errors, fraudulent labels and semaglutide salt forms.

As of May 31, 2026, FDA had received:

• 990 adverse-event reports associated with compounded semaglutide
• More than 730 adverse-event reports associated with compounded tirzepatide

FDA says those reports may be undercounted because many state-licensed pharmacies are not required to send adverse-event reports to FDA. It also says a report does not prove the compounded drug caused the event.

Those numbers are not Trimi-specific. They are the current backdrop for every compounded GLP-1 decision.

The enforcement backdrop, briefly

FDA launched a wider crackdown on misleading drug ads in September 2025. On March 3, 2026, it announced 30 warning letters to telehealth companies marketing compounded GLP-1 products with false or misleading claims. FDA has said telehealth companies should not call compounded products generic, the same as FDA-approved drugs, FDA-approved, FDA-licensed, or clinically proven to match an approved drug.

We searched FDA's warning-letter database for "Trimi Health" and trytrimi.com on August 28, 2026 and found no warning letter issued to Trimi. That is a negative search finding, not FDA approval or clearance.

Basic safety, once, plainly

The current FDA-approved Wegovy and Zepbound labels carry boxed warnings for thyroid C-cell tumors seen in rodents. The labels say it is unknown whether the drugs cause those tumors in humans. They are contraindicated if you or a family member has had medullary thyroid carcinoma or if you have MEN 2.

For weight loss, the Wegovy label says to stop when pregnancy is recognized and to stop semaglutide at least two months before a planned pregnancy. Discuss pregnancy plans before starting any semaglutide or tirzepatide product.

Talk with a clinician about your history if you've had pancreatitis, gallbladder disease, serious digestive problems, kidney problems, or diabetic eye disease. Common side effects include nausea, diarrhea, vomiting, constipation and stomach pain.

If an injectable GLP-1 arrives warm or with too little refrigeration, FDA recommends not using it. Contact the dispensing pharmacy and your clinician for instructions.

This page is general information. It isn't medical advice, and it isn't a substitute for a licensed clinician who knows your history.

If reading that changed your mind

Some people read this section and decide they want a medication the FDA has actually reviewed. That's a completely reasonable call, and it's a different treatment path — not a more expensive version of the same one.

Ro offers access to FDA-approved GLP-1 options and a free insurance-coverage check for the Ozempic, Wegovy and Zepbound pens. Ro's membership is $39 for the first month, then $74 to $149 per month depending on the plan. Medication is billed separately.

→ Check your GLP-1 insurance coverage with Ro (Sponsored) — Ro says the coverage report is free and does not submit a treatment request or write a prescription.

Sources: FDA: Compounding and the FDA — Questions and Answers, FDA's current compounded GLP-1 concerns, FDA's April 1, 2026 compounding-policy update, FDA telehealth marketing guidance, FDA's March 3, 2026 announcement, Wegovy prescribing information, Zepbound prescribing information, STEP 1, SURMOUNT-1, Ro pricing, Ro coverage checker.

What's included in a Trimi plan?

Trimi states its plans include the compounded medication, clinician review, ongoing portal messaging, dose adjustments when clinically appropriate, injection supplies, and free shipping, with no separate membership fee. We've labeled these as provider-stated because we didn't test the checkout or the fulfillment ourselves.

How Trimi says it works:

1. You complete an online health assessment. Trimi generally requires a BMI of 22 or higher to begin the intake. That is Trimi's screening threshold, not a promise that you will be prescribed.
2. A licensed clinician reviews your file. Trimi states this usually takes 24 to 48 hours.
3. If treatment is appropriate, the clinician writes a prescription.
4. A compounding pharmacy prepares the medication for you.
5. It ships to your door. Trimi states the full path from signup to delivery is usually two to four days, with free overnight shipping after compounding.
6. You message your care team through the portal for follow-ups and possible dose changes.

What's genuinely different here: flat advertised pricing at every dose, no separate membership fee stacked on top of the medication, and named pharmacies. Those three together are worth checking side by side.

Five things on Trimi's site do not match cleanly

These are why we recommend getting your own plan in writing:

• One Trimi pricing article says semaglutide starts at $125 in its summary while the pricing card on the same page shows $99 on the annual plan.
• Some Trimi marketing pages say you can cancel anytime without penalties, while the detailed refund policy says ordinary orders are final once a prescription is issued and discounted multi-month exits are reviewed case by case.
• Trimi's pricing page describes the three-month plan as $435 billed every three months. Its refund policy gives an example saying that if a three-month plan ends in month two, month three “also won't be charged.” Those statements do not fit cleanly because the pricing page describes the quarter as one upfront charge. Confirm the first charge and future billing schedule before you pay.
• Trimi's provider page currently shows Sean Arora, MD as licensed in 50 states and Shannon Arora, MD as licensed in 0 states.
• Trimi's public care pages name Arora Health, VialsRx and Greenwich Rx, while its Terms of Service still name Beluga Health and the Bask Pharmacy Network. The same terms also contain a long section for a testosterone program that is not the GLP-1 program reviewed here.

These may be website or template errors rather than a service problem. Big sites drift out of sync. But when the legal page, sales page and provider page tell different stories, confirm the exact clinician group, pharmacy, charge and cancellation terms for your order before the prescription is issued.

Sources: Trimi treatments and inclusions, Trimi reviews and care-process page, Trimi pricing article, Trimi provider page, Trimi Refund & Cancellation Policy, Trimi Terms of Service.

Is Trimi the same company as TrimRx? (And what about TRYM Health?)

No. Trimi, TrimRx and TRYM Health are three separate companies with similar-sounding names. The FDA warning letter discussed below was issued to TRYM Health, a different company.

FDA's letter to TRYM Health cited claims including “clinically proven” and statements that its compounded products contained the same active ingredient as named FDA-approved brands. FDA said those claims falsely implied the compounded products were the same as approved products.

That letter belongs to TRYM Health. It does not belong to Trimi Health or TrimRx.

If you meant to research TrimRx, we have a separate review for that. → Read our TrimRx review

We're spelling this out because mixing up three companies with nearly the same name can attach one company's regulatory history to another. That is not a small typo. It can cost someone a good decision.

Sources: FDA warning letter 716699 to TRYM Health, Trimi, TrimRx.

Who should use Trimi — and who shouldn't

Trimi fits a specific person: a cash-paying shopper who knowingly wants a compounded medication, cares most about price, will start month-to-month, and will confirm their pharmacy in writing first. It's a poor fit for anyone who needs an FDA-approved product, wants to use insurance, or can't afford to lose a payment they can't get back.

Trimi may be a good fit if:

• You're paying cash and price is your top priority
• You understand you're buying a compounded medication, not a brand-name drug
• You're going to start on the month-to-month plan
• Flat pricing matters to you as the prescribed dose changes
• You'll ask which pharmacy fills your order before the prescription is issued
• You'll log your starting weight in the portal on day one
• You've read the refund cutoff and you're fine with it

If that's you, that's a reasonable decision and you don't need anyone's permission to make it.

→ Start Trimi's clinician review and check eligibility (Provider site) Confirm your total first charge, clinical group and dispensing pharmacy before your prescription is issued.

Skip Trimi if:

• You want an FDA-approved medication. → See the FDA-approved path instead.
• You want Trimi to bill insurance. Trimi is a cash-pay program and states that it does not bill insurance.
• You cannot risk a non-refundable payment. → Start monthly or use a different provider.
• You're in California and Trimi will not name a pharmacy that can lawfully fill and ship your prescription there. → Find a path available in your state.
• The removed Trustpilot rating is a dealbreaker for you. That's a legitimate reason to walk away, and we're not going to talk you out of it.
• You're not sure yet whether you want compounded or FDA-approved. → Find My GLP-1 Path sorts that in about a minute.

We'd rather lose you here than have you find out in month four that this wasn't your fit.

How we reviewed Trimi

We built this page from Trimi's own published pricing, refund policy, terms, provider pages, state pages and pharmacy disclosures; from Trustpilot and Reviews.io captured on the same day; from two Texas pharmacy inspection reports; from California's enforcement record; and from current FDA guidance and warning letters.

We were not Trimi patients. We didn't buy a plan, receive medication, or test a vial. When Trimi says something we couldn't confirm, we wrote "Trimi states." When we checked something ourselves, we said what we found and where to find it.

On our commercial relationship: The RX Index may earn a commission from links marked “Sponsored” on this page. Our Trimi links go straight to Trimi's official site and are marked “Provider site.” We're telling you to skip the annual plan anyway. A reader who feels trapped isn't a customer, they're a complaint — and a page that sends people into a decision they regret is worthless to everyone, including us.

This page will change. Prices move, ratings move, policies move and pharmacy records move. We re-check the review platforms and pricing monthly, and the pharmacy records at least quarterly. The “last verified” date at the top is the real one.

Trimi GLP-1 reviews: frequently asked questions

Is Trimi Health legit?

Trimi is a real telehealth business with published prices, policies, a named public-facing clinical group and named pharmacies. That separates it from an anonymous medication storefront. It does not mean every claim is independently verified. Trustpilot's rating for Trimi is currently unavailable after a rules breach, so we recommend starting month-to-month rather than prepaying for a year.

Why was Trimi's Trustpilot rating removed?

Trustpilot says Trimi's rating is unavailable because the company breached its guidelines. A separate notice says Trustpilot removed fake reviews from the profile. Trustpilot does not say who submitted them. The 62 reviews still displayed were 53% one-star when checked August 28, 2026.

Is the $99 Trimi price real?

Yes, as an effective monthly rate — but only when you pay $1,188 up front for a full year of compounded semaglutide. The flexible month-to-month price is $175. Anyone quoting “$99 a month” without the annual charge is giving you half the picture.

How much is Trimi tirzepatide?

Trimi publishes compounded tirzepatide at $235 month-to-month, $199 per month on quarterly billing ($597 each quarter), $175 per month on six-month billing ($1,050 each six months), and $125 per month when you pay $1,500 once for a year. Trimi states the price stays the same at every dose.

Can I cancel Trimi and get a refund?

You can cancel for a full refund before a clinician issues your prescription. After that, Trimi's ordinary rule says the order is final. Trimi does not promise pro-rated refunds. Its current policy says early exits from discounted multi-month plans are reviewed case by case, and a separate six-month money-back promise has conditions.

Does Trimi have a money-back guarantee?

Trimi calls it a six-month money-back promise. For the no-weight-loss path, you must stay active for six continuous months, follow the prescribed schedule, complete check-ins, log a starting weight and a six-month weight in the portal, and file within 30 days of the six-month mark. Its policy also describes a satisfaction path after working with the care team. Because that sits next to a rule saying dissatisfaction with how a medication feels is not ordinarily refundable, get your eligibility in writing.

What pharmacy does Trimi use?

Trimi names VialsRx, tied to Texas license #35264, and Greenwich Rx. Texas inspection files listed zero deficiencies on the warning notice for license #35264 in February 2025 and March 2026. The newer report records the new name Believe Rx and a move to Tomball. Ask Trimi which legal pharmacy name will appear on your own prescription and label.

Is Trimi available in California?

Trimi advertises nationwide service, but California ordered Greenwich Rx — one of Trimi's two named pharmacies — to stop shipping compounded prescriptions into California effective May 18, 2026. The order names Greenwich Rx, not Trimi. A California reader should get the legal name and current California authority of the actual dispensing pharmacy in writing before the prescription is issued.

Are Trimi's medications FDA-approved?

No. Trimi sells compounded semaglutide and compounded tirzepatide. FDA does not review compounded drugs for safety, effectiveness or quality before sale. After the national shortages ended, a 503A prescription also needs to fit current federal compounding rules, including a documented patient-specific significant difference when the compounded drug is essentially a copy of an available approved drug.

Does Trimi take insurance or HSA/FSA?

Trimi is a cash-pay program and states that it does not bill insurance, so there is no insurance prior-authorization process through Trimi. Trimi says HSA and FSA cards are accepted. Whether your own purchase is eligible or needs more records is decided under your plan's rules, so save the itemized receipt and ask the plan administrator when needed.

Does Trimi have a BBB rating?

We did not find a Better Business Bureau profile for Trimi Health or trytrimi.com in our August 28, 2026 site search. That does not prove there has never been a complaint. It means there was no BBB profile for us to inspect.

What should I do if my Trimi medication isn't working?

Message your clinician in writing first. Ask the pharmacy for records tied to the lot on your vial and confirm whether the COA covers the finished compounded batch or only the ingredient lot. Ask separately for identity, potency, sterility and endotoxin results if needed. Do not raise the dose on your own. For a suspected quality problem or adverse event, contact the pharmacy and clinician and consider FDA MedWatch. For an actual billing error, contact the card issuer quickly.

Is Trimi the same as TrimRx?

No. Trimi and TrimRx are separate companies. A third company, TRYM Health, received FDA warning letter 716699 in September 2025. That letter belongs to TRYM Health, not Trimi.

So — should you use Trimi?

Our verdict: a conditional yes, on the month-to-month plan, after you confirm your pharmacy in writing.

Trimi's price is real, and flat dose pricing is a genuinely good feature. Texas inspection files show zero deficiencies on the warning notice for two inspections tied to the license number Trimi publishes, and the newer record explains the VialsRx-to-Believe Rx name and address change. That gives you more to check than a provider page that names no pharmacy at all.

What we cannot do is point you to a public rating that cleanly settles the question. Reviews.io leans strongly positive. Trustpilot pulled Trimi's score and says it removed fake reviews. The refund door closes earlier than many people expect. The legal pages do not match the public care pages. And one of Trimi's two named pharmacies is under a California cease-and-desist order.

None of that makes Trimi a scam. All of it makes prepaying $1,188 or $1,500 the wrong way to find out.

What would change our verdict: Trustpilot restoring the rating, a published independent test tied to a finished Trimi-dispensed batch, Trimi's legal and care pages naming the same clinical and pharmacy partners, or California lifting the Greenwich Rx order. We re-check ratings and prices monthly and pharmacy records at least quarterly.

Still not sure which GLP-1 program is right for you? Take our free 60-second matching quiz.

→ Get My Personalized GLP-1 Treatment Path

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Sources

1. Trimi Health — homepage, pricing claims, patient count and pharmacy disclosures. Verified August 28, 2026.
2. Trimi Health — pricing and promotions. Verified August 28, 2026.
3. Trimi Health — treatments, eligibility and plan inclusions. Verified August 28, 2026.
4. Trimi Health — Refund & Cancellation Policy, last updated June 17, 2026. Verified August 28, 2026.
5. Trimi Health — Terms of Service, revision date shown as May 11, 2024. Verified August 28, 2026.
6. Trimi Health — provider page, state-availability page, and reviews/care-process page. Verified August 28, 2026.
7. Trustpilot — Trimi Health profile. Captured August 28, 2026.
8. Reviews.io — Trimi company profile. Captured August 28, 2026.
9. Reviews.io — consumer FAQ on invitations, verification and removal. Retrieved August 28, 2026.
10. Texas State Board of Pharmacy — VialsRx inspection report, license #35264, March 18, 2026. Retrieved August 28, 2026.
11. Texas State Board of Pharmacy — Vital Drip Infusion Pharmacy inspection report, license #35264, February 5, 2025. Retrieved August 28, 2026.
12. California State Board of Pharmacy — Immediate Protection Orders, April 1–June 30, 2026, including the Greenwich Rx cease-and-desist order effective May 18, 2026. Retrieved August 28, 2026.
13. U.S. FDA — Compounding and the FDA: Questions and Answers. Retrieved August 28, 2026.
14. U.S. FDA — current concerns with unapproved compounded GLP-1 products, including adverse-event totals through May 31, 2026. Retrieved August 28, 2026.
15. U.S. FDA — April 1, 2026 clarification of compounding policy after GLP-1 supply stabilization. Retrieved August 28, 2026.
16. U.S. FDA — telehealth-company guidance for promoting compounded drugs. Retrieved August 28, 2026.
17. U.S. FDA — March 3, 2026 announcement of 30 warning letters to telehealth companies. Retrieved August 28, 2026.
18. U.S. FDA — Warning Letter 716699 to TRYM Health, September 9, 2025.
19. U.S. FDA — Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients and GLP-1 Import Alert 66-80, used to distinguish API-lot records from finished-preparation testing.
20. U.S. FDA — Wegovy prescribing information and Zepbound prescribing information. Retrieved August 28, 2026.
21. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity — STEP 1. N Engl J Med. 2021;384:989–1002.
22. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity — SURMOUNT-1. N Engl J Med. 2022;387:205–216.
23. Consumer Financial Protection Bureau — how to dispute a credit-card billing error. Retrieved August 28, 2026.
24. Ro — Body Program pricing and free GLP-1 insurance-coverage checker. Verified August 28, 2026.